... G. Steven Burrill and Kenneth B. Lee, Jr., “Biotech93: Accelerating Commercialization,” (San Francisco: Ernst & Young, 1992): 21. Burrill 2003: 390. Laura DeFrancesco, “2017-Venture Funding Goes into Overdrive,” Nature Biotechnology 36 ...
... Gayatri Saberwal, “Building Biotech in Australian,” tradesecrets (May 8 ... Japan (April 2016): 7. Available at www.ey.com/Publication/vwLUAssets/ey-life-sciences-sector-update-asiapacific-and-japan/$FILE/ey-life-sciences-sector-update-asia- ...
The Healthcare Value Chain: Demystifying the Role of GPOs and PBMs
... case, one GPO that was not implicated in any of the J&J/EES cases (listed above) commissioned an empirical study to ... Genicon—who had also brought lawsuits against J&J/EES—were clearly rated as inferior by physicians. The ConMed case ...
... biotechnology companies . Managing a biotechnology firm Without question ... you add the complexities , existing in most biotechnology companies , of ... entrepreneur is often selected to lead the start - up biotechnology firm as Chief ...
The U.S. Healthcare Ecosystem: Payers, Providers, Producers
